Webinar: Innovative assays for neurodegeneration drug discovery

Neurons in the brain

Neurodegenerative diseases are characterised by neuronal damage, degradation of the blood-brain barrier and failures in the normal repair mechanisms of the brain. Many of the most promising areas of drug development in this field target neuroinflammation and remyelination.

In this new on-demand webinar we use multiple sclerosis as a case-study of a neurodegenerative disease, so you can:

  • Understand the key processes in neurodegeneration
  • Discover how in vitro assays can be used to model in vivo neurodegeneration
  • Learn how to select the most appropriate assay for your drug target of interest

Brought to you by DDW and Malvern Panalytical, the webinar is presented by Dr Elise Malavasi, Principal Scientist at Concept Life Sciences.

Watch the webinar now.

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free